← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2021Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (44 distinct, 32 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (42 own, 0 via acquisition)
Recent trials (50)
- NCT07305935Sponsor investigatorN/AOct 1, 2025
- NCT07305935Lead sponsorN/AOct 1, 2025
- NCT07068256Lead sponsorN/AApr 1, 2025
- NCT07068256Sponsor investigatorN/AApr 1, 2025
- NCT07115121Lead sponsorN/AFeb 2, 2025
- NCT07115121Sponsor investigatorN/AFeb 2, 2025
- NCT07168304Lead sponsorN/AFeb 1, 2025
- NCT07168304Sponsor investigatorN/AFeb 1, 2025
- NCT07163572Sponsor investigatorN/AJan 16, 2025
- NCT07163572Lead sponsorN/AJan 16, 2025
- NCT07086937Lead sponsorN/AJan 1, 2025
- NCT07086937Sponsor investigatorN/AJan 1, 2025
- NCT07275593Lead sponsorN/ANov 3, 2024
- NCT07275593Sponsor investigatorN/ANov 3, 2024
- NCT07052136Lead sponsorN/ANov 1, 2024
Details
- Last known activity
- Oct 1, 2025